Clinical TrialsSearch results
Number of results: 195
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma:
the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- Effects of a traditional Japanse herbal medicine yokukansan (YKS) for BPSD in DLB
- Dementia with Lewy bodies (DLB), Parkinson disease with dementia (PDD)
- yokukansan-DLB research group
- 2008-11-20
Recruiting
- A New Phototubometry
- External and middle ear diseases
- Yazama Hiroaki
- 2019-05-29
Completed
- Safety and efficacy of TAME for chronic musculoskeletal pain refractory to non-surgical management
- Musculoskeletal chronic pain refractory to non-surgical management (Glenohumeral joint, elbow joint,
- Yata Shinsaku
- 2018-12-25
Recruiting
- ATB200/AT2221 Expanded Access Study in Adult Pompe disease Subject
- Pompe disease
- Wright Jacquelyn
- 2021-12-04
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
- All patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).
- West Japan Oncology Group
- 2005-08-22
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11